These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33836365)

  • 41. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
    Silverstone PH; Entsuah R; Hackett D
    Int Clin Psychopharmacol; 2002 Nov; 17(6):273-80. PubMed ID: 12409680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH; Andersen HF; Thase ME
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive modeling of antidepressant efficacy based on cognitive neuropsychological theory.
    Bian A; Xiao F; Kong X; Ji X; Fang S; He J; Liu Q; Zhong R; Yao S; Luo Q; ; Wang X
    J Affect Disord; 2024 Jun; 354():563-573. PubMed ID: 38484886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of the application of enhanced CT radiomics and machine learning in preoperative prediction of microvascular invasion in hepatocellular carcinoma].
    Yu YX; Hu CH; Wang XM; Fan YF; Hu MJ; Shi C; Hu S; Zhu M; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1239-1245. PubMed ID: 34865392
    [No Abstract]   [Full Text] [Related]  

  • 46. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA; Hanwella R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):8-16. PubMed ID: 21971532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.
    Herzallah MM; Moustafa AA; Natsheh JY; Danoun OA; Simon JR; Tayem YI; Sehwail MA; Amleh I; Bannoura I; Petrides G; Myers CE; Gluck MA
    J Affect Disord; 2013 Nov; 151(2):484-492. PubMed ID: 23953023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of machine learning model to predict osteoporosis based on abdominal computed tomography images of the psoas muscle: a retrospective study.
    Huang CB; Hu JS; Tan K; Zhang W; Xu TH; Yang L
    BMC Geriatr; 2022 Oct; 22(1):796. PubMed ID: 36229793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries.
    Fugger G; Bartova L; Fabbri C; Fanelli G; Dold M; Swoboda MMM; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):715-727. PubMed ID: 34989830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
    J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor analysis of electroacupuncture and selective serotonin reuptake inhibitors for major depressive disorder: an 8-week controlled clinical trial.
    Yang X; Gong W; Ma X; Wang S; Wang X; Guo T; Guo Z; Sun Y; Li J; Zhao B; Tu Y
    Acupunct Med; 2020 Feb; 38(1):45-52. PubMed ID: 31544488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.
    Feng X; Hong T; Liu W; Xu C; Li W; Yang B; Song Y; Li T; Li W; Zhou H; Yin C
    Front Endocrinol (Lausanne); 2022; 13():1054358. PubMed ID: 36465636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction.
    Bai Z; Hu S; Wang Y; Deng W; Gu N; Zhao R; Zhang W; Ma Y; Wang Z; Liu Z; Shen C; Shi B
    Ann Transl Med; 2021 Jul; 9(14):1162. PubMed ID: 34430603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study.
    Zandvakili A; Philip NS; Jones SR; Tyrka AR; Greenberg BD; Carpenter LL
    J Affect Disord; 2019 Jun; 252():47-54. PubMed ID: 30978624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction Model of Osteonecrosis of the Femoral Head After Femoral Neck Fracture: Machine Learning-Based Development and Validation Study.
    Wang H; Wu W; Han C; Zheng J; Cai X; Chang S; Shi J; Xu N; Ai Z
    JMIR Med Inform; 2021 Nov; 9(11):e30079. PubMed ID: 34806984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study.
    Wang Y; Lang J; Zuo JZ; Dong Y; Hu Z; Xu X; Zhang Y; Wang Q; Yang L; Wong STC; Wang H; Li H
    Eur Radiol; 2022 Dec; 32(12):8737-8747. PubMed ID: 35678859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.